Owner & Principal at BioPharma Law Group, PLLC | United States of America (USA)
Joanna is a patent attorney who focuses her practice on all aspects of services related to patents in the areas of biotechnology, pharmaceuticals and medical devices, including patentability opinions, patent drafting, domestic and foreign patent prosecution, development and management of patent portfolios, and general client counseling during all phases of a product’s lifecycle, from concept to commercialization.
Joanna’s patent experience covers a variety of complex and innovative inventions involving small molecule drugs, biologics, cell-based technologies, compositions, drug formulations, and drug delivery systems, immunotherapeutics, medical devices, diagnostic tests, and immunology, particularly vaccines and antibodies. Joanna also has experience counseling clients on the Hatch-Waxman Act and is monitoring developments involving biosimilars under the Biologics Price Competition and Innovation Act.
Joanna also has extensive experience counseling clients on domestic and international legal and contractual matters, including issues related to U.S. and global clinical trials, intellectual property, technology licensing, laboratory services, joint development, research and development, manufacturing, consulting, confidential disclosure, material transfer, and other related agreements.
Joanna is also an Adjunct Lecturer at the Harvard School of Public Health where she teaches a course on Intellectual Property and Health Technologies. She regularly speaks or lectures on intellectual property-related topics and is a frequent author of articles related to patent law and healthcare. In 2013, Joanna published a book called “Intellectual Property and Health Technologies: Balancing Innovation and the Public’s Health” which examines the relationship between patents and public health in the context of medical technologies. She was also selected for the 2014 National Law Journal’s list of Boston’s Rising Stars.